Dr. Jonathan Beilan

Dr. Jonathan Beilan
Dr. Jonathan Beilan is a highly trained board-certified urologist working at Advanced Urology Institute in Largo, FL. Dr. Beilan completed his Male Reproductive Medicine and Microsurgery Fellowship with Dr. Lipshultz in Houston, Texas in 2019. Dr. Jonathan Beilan was born and raised on the Gulf Coast of Florida in New Port Richey. He received his undergraduate degree in Molecular Biology and Microbiology from the University of Central Florida. In 2009, he was selected to be part of the UCF College of Medicine’s inaugural class in Orlando, Florida. Dr. Beilan completed his general surgery internship and urologic residency at the University of South Florida in Tampa, Florida. Here, Dr. Beilan became well-versed with complex male prosthetic surgical cases as well as the management of male voiding symptoms including as BPH-related conditions. He then completed his clinical fellowship at Baylor College of Medicine in 2018-2019. Dr. Beilan now specializes in erectile dysfunction and other men’s health issues, including sexual problems such as Peyronie’s disease and low testosterone, as well as male infertility and voiding dysfunction. With offices in Largo and Palm Harbor, FL, Dr. Beilan serves the greater Tampa Bay community with regard to BPH, male fertility, sexual medicine, and men’s health issues. He is an active member within the AUI/Solaris family and remains committed to patient and trainee education. In 2022, Dr. Beilan was appointed as an Assistant Professor to the Collaborative Faculty of the USF Department of Urology, and currently hosts USF REI fellows as part of their male reproductive medicine rotation. Dr. Beilan is also a member of of the Sexual Medicine Society of North America (SMSNA), American Urological Association (AUA) and its Southeastern Section (SESAUA), the American Society for Reproductive Medicine (ASRM), and the Society for Male Reproduction and Urology (SMRU).
Medical School:

University of Central Florida College of Medicine


University of South Florida Morsani College of Medicine


Baylor College of Medicine


University of Central Florida

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only